Nasus Pharma Ltd Restricted Cash
Nasus Pharma Ltd (NSRX) had Restricted Cash of $54.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2026-03-25
- 2025-12-31: Restricted Cash $54.00K.
- 2025-06-30: Restricted Cash $29.00K.
- 2024-12-31: Restricted Cash $27.00K.
- 2024-06-30: Restricted Cash $16.00K.
| Period end | Restricted Cash |
|---|---|
| 2025-12-31 | $54.00K 20-F · filed 2026-03-25 |
| 2025-06-30 | $29.00K 6-K · filed 2025-12-29 |
| 2024-12-31 | $27.00K 20-F · filed 2026-03-25 |
| 2024-06-30 | $16.00K 6-K · filed 2025-12-29 |
| 2023-12-31 | $17.00K 20-F · filed 2026-03-25 |